Shares of Merck KGaA (ETR:MRK – Get Free Report) rose 1.1% on Thursday. The stock traded as high as €146.85 and last traded at €146.05. 206,624 shares traded hands during mid-day trading, The stock had previously closed at €144.50.
Merck KGaA Stock Performance
The firm has a market capitalization of $65.04 billion, a price-to-earnings ratio of 23.99, a price-to-earnings-growth ratio of 2.37 and a beta of 0.79. The company has a debt-to-equity ratio of 40.77, a quick ratio of 0.72 and a current ratio of 1.69. The stock’s fifty day moving average is €137.84 and its two-hundred day moving average is €129.05.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.
Featured Articles
- Five stocks we like better than Merck KGaA
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
